FineMark National Bank & Trust decreased its position in CME Group Inc (NASDAQ:CME) by 9.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,168 shares of the financial services provider’s stock after selling 3,181 shares during the period. FineMark National Bank & Trust’s holdings in CME Group were worth $5,662,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the company. Parnassus Investments CA purchased a new stake in CME Group during the second quarter worth about $544,292,000. Janus Henderson Group PLC boosted its holdings in CME Group by 10.7% during the first quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after buying an additional 603,645 shares in the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after buying an additional 537,917 shares in the last quarter. FMR LLC boosted its holdings in CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after buying an additional 355,566 shares in the last quarter. Finally, AKO Capital LLP boosted its holdings in CME Group by 54.6% during the second quarter. AKO Capital LLP now owns 935,264 shares of the financial services provider’s stock worth $181,544,000 after buying an additional 330,305 shares in the last quarter. 84.99% of the stock is currently owned by institutional investors and hedge funds.
In other news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total transaction of $503,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 in the last ninety days. 1.20% of the stock is currently owned by company insiders.CME has been the topic of a number of research analyst reports. UBS Group boosted their price objective on shares of CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a report on Monday, May 27th. Barclays upped their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Wells Fargo & Co upped their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $196.85.
Shares of NASDAQ:CME traded up $0.42 during trading on Friday, reaching $205.80. The stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. CME Group Inc has a fifty-two week low of $161.05 and a fifty-two week high of $224.91. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The business has a fifty day moving average price of $211.25 and a 200-day moving average price of $191.16. The stock has a market cap of $72.54 billion, a P/E ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $1.74 earnings per share. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc will post 6.69 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.46%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What causes a yield curve to invert?
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.